Pioneering diagnostics

Committed to being a socially responsible Company, with a humanistic vision

As a pioneer in the field of in vitro diagnostics, bioMérieux has been committed to fighting infectious diseases worldwide for more than 55 years. Our company has always adopted a socially responsible, humanistic approach to business development in line with the values upheld by the Mérieux family.

The employees of bioMérieux find meaning in their work thanks to the Company’s commitment to serve public health. Worldwide, we take action to support them on their career paths so they can develop new skills in a constantly-changing environment.
We implement an ambitious HR policy to ensure that a bioMérieux career is an experience that brings a sense of worth and motivation as well as respect for the balance between their professional and personal lives. Although we operate in over 160 countries today, we continue to place particular importance on the close ties to our home region, which provides the longstanding, solid foundation for our development.

 

Michel Baguenault

Corporate Vice President, General Secretary

 

 

 

 

We take a long-term view when it comes to our employees as well as to outside stakeholders and the community in general. Our public health mission means we have a particular responsibility to today’s society and future generations.

Through our activities, bioMérieux supports the advancement of the United Nations Sustainable Development Goals (SDG), which aim to provide a blueprint to build a better and more sustainable future for all.

 

The UN Global Compact

Each year since 2003, we have renewed our support for the United Nations Global Compact. bioMérieux has committed to respecting the key principles set out in the Global Compact, based on four pillars: respect for human rights, labor conditions, the environment and the fight against corruption 

Recognition of our corporate social responsibility policy

For several years, extra-financial agencies have recognized bioMérieux’s commitment to corporate social responsibility (CSR). These agencies, which evaluate the company’s social, societal and environmental performance, have included bioMérieux in their SRI (Socially Responsible Investment) indices, such as the Ethibel Forum (Ethibel Sustainability Index (ESI) Excellence Europe) and FTSE Russell (FTSE4Good Index). After joining additional indices in 2017, bioMérieux obtained new labels: Vigeo Eiris, OEKOM Research, CDP (Carbon Disclosure Project) and EcoVadis. In 2018, the Company was listed in the Corporate Knights Global 100 Index.

 

  

 

  • In 2018, EcoVadis ranked bioMérieux among the top 1% of companies recognized for their CSR performance with a 72/100 score, up compared to the previous year.
  • In 2019, bioMérieux was listed 26th on Corporate Knights Corporate 100 index, worldwide ranking of the most sustainable companies with more than 1 billion dollars revenue.